What is Proficient Rx?
Proficient Rx specializes in offering comprehensive point-of-care medication and dispensing programs tailored for a wide array of licensed healthcare providers. The company's core service involves prepackaging, labeling, and distributing dispense-ready medications directly to medical practices and clinics. Proficient Rx ensures the highest quality, FDA-approved prepackaged medications in "unit-of-use" quantities, precisely as requested by physicians. All pharmaceuticals are repackaged within the company's VAWD accredited, DEA and FDA approved facility, adhering to an rigorous 18-step quality control process to guarantee purity, safety, and traceability. The company's advanced facility is equipped with multiple production rooms capable of packaging all legend drugs and controlled substances, including Schedules 2, 3, 3N, 4, and 5, alongside OTC products, vitamins, and nutraceuticals.
How much funding has Proficient Rx raised?
Proficient Rx has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Proficient Rx
PPP
Public-Private Partnership
What's next for Proficient Rx?
The substantial enterprise-level funding and recent strategic investment signal a strong confidence in Proficient Rx's business model and its capacity for further expansion. This capital infusion is expected to fuel advancements in their dispensing technology, enhance operational capabilities, and potentially broaden their market reach within the healthcare provider network. Proficient Rx is strategically positioned to capitalize on the growing demand for efficient and compliant medication dispensing solutions at the point of care, aiming to solidify its leadership in this specialized segment of the pharmaceutical supply chain.
See full Proficient Rx company page
